Cleared Traditional

K771875 - ULTRAFILTRATION MONITOR 5M9034

K771875 is the FDA 510(k) clearance for ULTRAFILTRATION MONITOR 5M9034 by Travenol Laboratories, S.A.. It is a Class 2 Hematology device (product code FIL) cleared through the Traditional 510(k) pathway after a 56-day FDA review.

K771875 · Travenol Laboratories, S.A. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1977
Decision
56d
Days
Class 2
Risk

K771875 is an FDA 510(k) clearance for the ULTRAFILTRATION MONITOR 5M9034. Classified as System, Dialysate Delivery, Single Pass (product code FIL), Class II - Special Controls.

Submitted by Travenol Laboratories, S.A. (Mchenry, US). The FDA issued a Cleared decision on November 30, 1977 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 876.5820 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Travenol Laboratories, S.A. devices

Submission Details

510(k) Number K771875 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 05, 1977
Decision Date November 30, 1977
Days to Decision 56 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
57d faster than avg
Panel avg: 113d · This submission: 56d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FIL System, Dialysate Delivery, Single Pass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5820
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - FIL System, Dialysate Delivery, Single Pass

Devices cleared under the same product code (FIL) and FDA review panel - the closest regulatory comparables to K771875.
SPS 550-IPS (INTEGRATED PATIENT STATION)
K901038 · Baxter Healthcare Corp · Apr 1990
FRESENIUS 2008 BSS BEDSIDE DIALYSIS SYSTEM
K890329 · Fresenius USA, Inc. · May 1989
ULTRAFILTRATION SCALE
K781633 · Extracorporeal Medical Specialities, Inc. · Dec 1978
AK-10
K771227 · Gambro, Inc. · Aug 1977
NEGATIVE PRESSURE ADAPTER 5M1350
K770137 · Travenol Laboratories, S.A. · Feb 1977